News Center

• Jun. 21

  2023

  VOLUNTARY ANNOUNCEMENT - MIRABEGRON EXTENDED-RELEASE TABLETS OBTAINS DRUG REGISTRATION APPROVAL

• Jun. 20

  2023

  Big News! Research Achievements of CSPC Published in The Lancet

• Jun. 08

  2023

  CSPC Pharma Releases Latest Studies on SYSA1801 at ASCO Annual Meeting

• Jun. 05

  2023

  VOLUNTARY ANNOUNCEMENT - CLINICAL DATA OF ALMB-0168 FOR THE TREATMENT OF OSTEOSARCOMA TO BE PRESENTED AT THE 2023 ASCO ANNUAL MEETING

• May. 18

  2023

  CSPC Amplifies Global Voice Stage Through Technological Innovation

• May. 04

  2023

  VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF PRUSOGLIPTIN TABLETS